Business · Updated 12 Oct, 07:11 pm IST
API Holdings cuts FY26 loss 67% to ₹520 crore
Why it matters for readers: Explains why the company is losing less money: better products, private brands and smarter discounts.
- Consolidated net loss fell 67% to ₹520 crore in the fiscal year ended March 2026, from ₹1,572 crore the prior year.1
- Operating revenue grew 12.7% year‑on‑year to ₹6,618.5 crore, and total revenue including other income was ₹6,689.2 crore.1
- The company cited focus on higher‑margin products, private label brands and optimising discounts in its B2R business for improved margins.1
- PharmEasy’s B2C business posted ₹348 crore revenue with EBITDA losses narrowing to ₹17 crore; B2B grew 8.2% to ₹1,006 crore in the first quarter of FY27.1
- In Q1 FY27, revenue rose about 10% YoY to ₹1,754 crore and EBITDA increased to ₹39.3 crore, with gross margin improving to 21.4%.1
Get a brief like this every morning
Uzha reads hundreds of sources and gives you the stories that matter for your work, with every source linked. Free.
Get started